Search alternatives:
teer decrease » greater decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11881
-
11882
-
11883
Schematic of the treatment procedure.
Published 2023“…Conversely, VitD treatment altered this scenario into motor performance preservation, reducing oxidative splenic injury with a decrease in the percent apoptotic index. This protection was significantly correlated with preserving leukocyte counts and reduced MDA levels in both genders. …”
-
11884
S1 Raw images -
Published 2023“…Conversely, VitD treatment altered this scenario into motor performance preservation, reducing oxidative splenic injury with a decrease in the percent apoptotic index. This protection was significantly correlated with preserving leukocyte counts and reduced MDA levels in both genders. …”
-
11885
Animal grouping and treatment.
Published 2023“…Compared with the model group, the petroleum ether extract-treated group showed significant differences in the levels of TNF-α (161.67±4.93, 106.33±3.21, 77.67±4.04 pg/mL) and IL-10 (291.77±4.93, 185.09±9.54, 141.33±1.53 pg/mL) on the 7<sup>th</sup>, 14<sup>th</sup>, and 21<sup>st</sup> days; a significant difference in the content of TGF-<i>β</i>1 (75.68±3.06 pg/mL) on the 21<sup>st</sup> day; and a significant difference in the level of VEGF (266.67±4.73, 311.33±10.50 pg/mL) on the 7<sup>th</sup> and 14<sup>th</sup> days respectively.…”
-
11886
Change in percent contracture rate of wound ().
Published 2023“…Compared with the model group, the petroleum ether extract-treated group showed significant differences in the levels of TNF-α (161.67±4.93, 106.33±3.21, 77.67±4.04 pg/mL) and IL-10 (291.77±4.93, 185.09±9.54, 141.33±1.53 pg/mL) on the 7<sup>th</sup>, 14<sup>th</sup>, and 21<sup>st</sup> days; a significant difference in the content of TGF-<i>β</i>1 (75.68±3.06 pg/mL) on the 21<sup>st</sup> day; and a significant difference in the level of VEGF (266.67±4.73, 311.33±10.50 pg/mL) on the 7<sup>th</sup> and 14<sup>th</sup> days respectively.…”
-
11887
General observation of the wound.
Published 2023“…Compared with the model group, the petroleum ether extract-treated group showed significant differences in the levels of TNF-α (161.67±4.93, 106.33±3.21, 77.67±4.04 pg/mL) and IL-10 (291.77±4.93, 185.09±9.54, 141.33±1.53 pg/mL) on the 7<sup>th</sup>, 14<sup>th</sup>, and 21<sup>st</sup> days; a significant difference in the content of TGF-<i>β</i>1 (75.68±3.06 pg/mL) on the 21<sup>st</sup> day; and a significant difference in the level of VEGF (266.67±4.73, 311.33±10.50 pg/mL) on the 7<sup>th</sup> and 14<sup>th</sup> days respectively.…”
-
11888
-
11889
-
11890
-
11891
Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 and -2
Published 2011“…All results are expressed as mean ± SD. WT Control vs Glutamate: < 0.01; WT Control vs Glutamate+hrC5a: **< 0.0001; C5aRKO Control vs Glutamate: *< 0.006; C5aRKO Control vs Glutamate+hrC5a: *< 0.006.…”
-
11892
Duty cycle of 33% increases cardiac output during cardiopulmonary resuscitation
Published 2020“…The primary outcome was ETCO<sub>2</sub> during CPR, and the secondary outcomes were coronary perfusion pressure (CPP), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), and right atrial pressure (RAP).</p><p>Results</p><p>Mean ETCO<sub>2</sub> was higher in the DC33 group compared with the DC50 group (22.5 mmHg vs 21.5 mmHg, P = 0.018). …”
-
11893
-
11894
-
11895
-
11896
-
11897
-
11898
-
11899
-
11900
Rhythmic recruitment of PRMT5 to the <i>Per1</i> gene promoter coincides with enrichment dimethylated H4R3.
Published 2012“…(C) Knock-down of <i>Prmt5</i> results in decreased dimethylation of H4R3 and recruitment of CRY1 to the <i>Per1</i> gene promoter. …”